Drug Information

Drug General Information
Drug ID
D0C0NH
Former ID
DCL000443
Drug Name
Avastin+/-Tarceva
Drug Type
Small molecular drug
Indication Non-small cell lung cancer [ICD10:C33-C34] Phase 3 [551595]
Company
Genentech
Formula
C10H6O3
PubChem Compound ID
3806
Target and Pathway
Target(s) Vascular endothelial growth factor Target Info Inhibitor [550797], [550798]
References
Ref 551595Clinical pipeline report, company report or official report of Roche.
Ref 550797Clinical pipeline report, company report or official report of Genentech (2009).
Ref 550798Clinical pipeline report, company report or official report of Genentech (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.